Chimeric Therapeutics (ASX:CHM) Update / Briefing September 08, 2025 08:00 PM ET Company ParticipantsRebecca McQualter - CEOJason Litten - Chief Medical OfficerJennifer R Eads - Professor - Clinical MedicineRebecca McQualterGood morning, everyone, and welcome to the Chimeric Therapeutics webinar this morning. I'm delighted to be joined by Dr. Jason Litton, who's in California, and Professor Jennifer Eads today, who's in Philadelphia. I really want to thank them for giving up their evenings to present to you ...